Concepedia

John O. DaSilva

JO

9

Publications

498

Citations

9

H-Index

2003

Active since

Affiliations

Regeneron (United States)(Current)

Progenics Pharmaceuticals (United States)

State University of New York

Stony Brook University

University of Virginia

John O. DaSilva is an author at Regeneron (United States) specializing in medicine, cell biology, and natural sciences.

ORCID

Top concepts

Publications per year

2003–2023

9

Publications

9

hSpry2 Is Targeted to the Ubiquitin-Dependent Proteasome Pathway by c-Cbl

Amy B. Hall, Natalia Jura, John O. DaSilva et al. · Current Biology · 2003 · 139 citations · Full text

, , +7

Regulation of Sprouty Stability by Mnk1-Dependent Phosphorylation

John O. DaSilva, Lizhong Xu, Hong Joo Kim et al. · Molecular and Cellular Biology · 2006 · 78 citations · Full text

, , +15

The Neuroendocrine-Derived Peptide Parathyroid Hormone–Related Protein Promotes Prostate Cancer Cell Growth by Stabilizing the Androgen Receptor

John O. DaSilva, Daniel Gioeli, Michael J. Weber et al. · Cancer Research · 2009 · 59 citations · Full text

Inhibition of Neurotensin Receptor 1 Selectively Sensitizes Prostate Cancer to Ionizing Radiation

Nicholas C.K. Valerie, Eli V. Casarez, John O. DaSilva et al. · Cancer Research · 2011 · 48 citations

Preclinical Study of a Biparatopic METxMET Antibody–Drug Conjugate, REGN5093-M114, Overcomes MET-driven Acquired Resistance to EGFR TKIs in EGFR-mutant NSCLC

Seung Yeon Oh, You Won Lee, Eun Ji Lee et al. · Clinical Cancer Research · 2022 · 46 citations · Full text

Rows per page

1–5 of 9